Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.307 USD | +0.52% | -1.38% | -6.83% |
Apr. 05 | RTW Biotech invests in cell and gene therapy company Obsidian | AN |
Apr. 02 | EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises | AN |
Financials (USD)
Sales 2021 | 0.66 | Sales 2022 | 2.17 | Capitalization | 257M |
---|---|---|---|---|---|
Net income 2021 | -64M | Net income 2022 | -39M | EV / Sales 2021 | 564,951,510 x |
Net cash position 2021 | 6.48M | Net cash position 2022 | 6.97M | EV / Sales 2022 | 115,364,471 x |
P/E ratio 2021 |
-5.88
x | P/E ratio 2022 |
-6.52
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.75% |
Latest transcript on RTW Biotech Opportunities Ltd
1 day | +0.52% | ||
1 week | -1.38% | ||
Current month | -1.01% | ||
1 month | +0.52% | ||
3 months | -7.33% | ||
6 months | +14.62% | ||
Current year | -6.83% |
Members of the board | Title | Age | Since |
---|---|---|---|
William Simpson
CHM | Chairman | 68 | - |
Paul Le Page
BRD | Director/Board Member | - | 19-10-29 |
William Scott
BRD | Director/Board Member | 64 | 19-10-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 1.307 | +0.52% | 8 879 |
24-05-01 | 1.3 | 0.00% | 91,915 |
24-04-30 | 1.3 | -1.14% | 549,653 |
24-04-29 | 1.315 | +0.38% | 116,243 |
24-04-26 | 1.31 | -1.13% | 237,817 |
Delayed Quote London S.E., May 02, 2024 at 04:27 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-6.83% | 500M | |
+4.09% | 12.65B | |
+7.44% | 9.05B | |
-3.81% | 5.38B | |
+7.82% | 5.5B | |
+6.24% | 5.22B | |
+15.27% | 4.36B | |
+10.77% | 4.36B | |
+1.29% | 3.97B | |
+3.73% | 3.84B |
- Stock Market
- Equities
- RTWG Stock